Literature DB >> 19156531

Relationships between cancer and aging: a multilevel approach.

Vladimir N Anisimov1, Ewa Sikora, Graham Pawelec.   

Abstract

The incidence of cancer increases with age in humans and in laboratory animals alike. There are different patterns of age-related distribution of tumors in different organs and tissues. Aging may increase or decrease the susceptibility of various tissues to initiation of carcinogenesis and usually facilitates promotion and progression of carcinogenesis. Aging may predispose to cancer in two ways: tissue accumulation of cells in late stages of carcinogenesis and alterations in internal homeostasis, in particular, alterations in immune and endocrine systems. Increased susceptibility to the effects of tumor promoters is found both in aged animals and aged humans, as predicted by the multistage model of carcinogenesis. Aging is associated with a number of events at the molecular, cellular and physiological levels that influence carcinogenesis and subsequent cancer growth. An improved understanding of age-associated variables impacting on the tumor microenvironment, as well as the cancer cells themselves, will result in improved treatment modalities in geriatric oncology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156531     DOI: 10.1007/s10522-008-9209-8

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  15 in total

Review 1.  Polyphenols and aging.

Authors:  Brannon L Queen; Trygve O Tollefsbol
Journal:  Curr Aging Sci       Date:  2010-02

Review 2.  The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span.

Authors:  Primož Rožman
Journal:  Geroscience       Date:  2018-06-14       Impact factor: 7.713

3.  Risk factors for postoperative pneumonia in elderly patients with colorectal cancer: a sub-analysis of a large, multicenter, case-control study in Japan.

Authors:  Masatoshi Kochi; Takao Hinoi; Hiroaki Niitsu; Hideki Ohdan; Fumio Konishi; Yusuke Kinugasa; Takaya Kobatake; Masaaki Ito; Masafumi Inomata; Toshimasa Yatsuoka; Takashi Ueki; Jo Tashiro; Shigeki Yamaguchi; Masahiko Watanabe
Journal:  Surg Today       Date:  2018-03-29       Impact factor: 2.549

Review 4.  Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy.

Authors:  Dallas B Flies; Britt J Sandler; Mario Sznol; Lieping Chen
Journal:  Yale J Biol Med       Date:  2011-12

Review 5.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 6.  Two-Step Senescence-Focused Cancer Therapies.

Authors:  Cynthia J Sieben; Ines Sturmlechner; Bart van de Sluis; Jan M van Deursen
Journal:  Trends Cell Biol       Date:  2018-05-17       Impact factor: 20.808

7.  Prevention of neuromusculoskeletal frailty in slow-aging ames dwarf mice: longitudinal investigation of interaction of longevity genes and caloric restriction.

Authors:  Oge Arum; Zachary Andrew Rasche; Dustin John Rickman; Andrzej Bartke
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

Review 8.  Metformin in obesity, cancer and aging: addressing controversies.

Authors:  Lev M Berstein
Journal:  Aging (Albany NY)       Date:  2012-05       Impact factor: 5.682

9.  The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages.

Authors:  Wouter B Aan de Stegge; Barbara L van Leeuwen; Marloes A G Elferink; Geertruida H de Bock
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  Reference Intervals of Alpha-Fetoprotein and Carcinoembryonic Antigen in the Apparently Healthy Population.

Authors:  Gao-Ming Zhang; Xu-Xiao Guo; Xiao-Bo Ma; Guo-Ming Zhang
Journal:  Med Sci Monit       Date:  2016-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.